Skip to main content

Identifying the Challenges of Treating Dual Conditions: COVID-19 and Hematologic Malignancies

November 07, 2020

php logoLindsey Roeker, MD, physician, Memorial Sloan Kettering Cancer Center, discusses the intersection of COVID-19 and hematologic malignancies—which encompasses numerous diseases with different considerations—highlighting how the pandemic uniquely impacts each of these patient populations, and identifies the challenges associated with making treatment decisions when there is still limited data.  


Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
5 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top